Document is current
Any future updates will be listed below
-
Authors
Little, Jessica S. https://orcid.org/0000-0001-8093-5647
Dedrick, Rebekah M. https://orcid.org/0000-0002-3666-711X
Freeman, Krista G. https://orcid.org/0000-0002-2944-5076
Cristinziano, Madison
Smith, Bailey E.
Benson, Constance A.
Jhaveri, Tulip A.
Baden, Lindsey R.
Solomon, Daniel A.
Hatfull, Graham F. https://orcid.org/0000-0002-6705-6821
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (GM131729)
Howard Hughes Medical Institute (GT12053)
Cystic Fibrosis Foundation (HATFUL19GO)
- License Information
-
More Information
Article History
Received: 22 December 2021
Accepted: 24 March 2022
First Online: 3 May 2022
Competing interests
: C.A.B. receives contract and grant funding from Gilead. G.F.H. acts as consultant and grant recipient for Janssen pharmaceuticals. The remaining authors declare no competing interests.
